CSF2 and myeloid sarcoma: B cell abnormalities reported in MS patients include an abnormal propensity to produce proinflammatory cytokines including IL-6, GM-CSF, TNF, and lymphotoxin-α and a deficiency in regulatory cytokines such as IL-10 [31,32,33].